A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis (Q61774659)
Jump to navigation
Jump to search
scientific article published on 06 March 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis |
scientific article published on 06 March 2012 |
Statements
A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis (English)
Ilona Cunningham
John Moore
Paul Cannell
Steve Gibbons
Jill Tate
Helen Mar Fan
H Miles Prince
Devinder S Gill